Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 34 clinical trials
Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine and Isoniazid or Standard Isoniazid Preventive Therapy in HIV+ Patients (DOLPHIN & DOLPHIN TOO)

undetectable (Groups 1 and 2) or detectable (Group 3 and 4) HIV viral load and an indication for TPT, will be switched to DTG with tenofovir/emtricitabine (Groups 1 and 2) or lamivudine/tenofovir (Groups 3 and

reverse transcriptase inhibitor
hiv viral load
efavirenz
emtricitabine
nevirapine
  • 34 views
  • 18 Sep, 2021
  • 1 location
Contingency Management for Cannabis Use for Persons With HIV

withdrawal, HIV viral load and biomarkers of systemic inflammation among PLWH and who use cannabis regularly (weekly or more often). This will be a single arm pilot feasibility trial involving a contingency

hiv viral load
HIV Vaccine
  • 0 views
  • 30 Jul, 2021
  • 2 locations
Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals

neutralizing antibodies are associated with CD4 lymphocyte counts, CD8 lymphocyte counts, CD4 nadir, HIV viral load and use of antiretroviral therapy. To assess the yellow fever vaccine viremia at day 10 after

vaccination
viremia
hiv viral load
antiretroviral agents
HIV Vaccine
  • 6 views
  • 22 Jan, 2021
  • 1 location
Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC)

-risk for HIV have the potential to continue transmission, making it difficult to end the epidemic. Rapid, Point-of-Care (POC) HIV viral load (VL) testing alleviates this problem by reducing TATs that

hiv test
pre-exposure prophylaxis (prep)
injection drug
HIV Vaccine
antiretroviral
  • 0 views
  • 10 Sep, 2021
  • 3 locations
Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat'

receive study treatment for 48 weeks. The two therapies will be compared by the change in HIV viral load from start of treatment to 12 weeks. Further clinical data will be recorded for the trial patients

AIDS
darunavir
emtricitabine
antiretroviral therapy
cobicistat
  • 0 views
  • 24 Jun, 2021
  • 3 locations
Youth Services Navigation Intervention for HIV+ Adolescents and Young Adults Being Released From Incarceration

, only an estimated 6% of HIV+ youth achieve HIV viral load suppression, due to poor retention and adherence to anti-retroviral therapy (ART). Existing linkage and retention services are insufficient to

hiv viral load
antiretroviral therapy
substance use
  • 1 views
  • 20 Mar, 2021
  • 1 location
Leveraging mHealth and Peers to Engage African- Americans and Latinxs in HIV Care (LEAN)

This is a pragmatic randomized controlled study comparing existing linkage to care and retention (LTCR) services to an mHealth-enhanced linkage to care and retention (mLTCR) protocol.

hiv diagnosis
  • 0 views
  • 18 Mar, 2021
  • 1 location
Trial of Ixazomib for Kaposi Sarcoma

This phase II trial studies how well ixazomib works in treating patients with Kaposi sarcoma. Ixazomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

  • 0 views
  • 08 Apr, 2021
  • 2 locations
A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention

Strategies to improve uptake of cardiovascular disease preventive therapies among people living with HIV (PLHIV) are urgently needed. This study tests an innovative prevention nurse intervention to extend the HIV/AIDS treatment cascade for the treatment of hypertension and hyperlipidemia among PLHIV on suppressive antiretroviral therapy. This intervention may be scalable …

AIDS
coronary artery disease
diabetes
hiv viral load
hypertension
  • 0 views
  • 25 Jan, 2021
  • 2 locations
HIV Treatment Adherence Dose Determination Trial

The proposed research will conduct the first dose-determination trial to find the optimal number of behavioral counseling sessions (dose) needed to achieve and sustain optimal HIV treatment adherence. The results of this study will determine how much intervention is needed for whom and at what cost to guide health policy …

antiretroviral
HIV Vaccine
antiretroviral therapy
  • 0 views
  • 26 Jan, 2021
  • 2 locations